Sign in to confirm you’re not a bot
This helps protect our community. Learn more

【CEO INTERVIEW| INmune Bio CEO/CMO Raymond J. Tesi, MD】

Wall Street Multimedia, Inc.
3K subscribers
566 views 5 years ago
INmune Bio Inc. is a clinical stage biotechnology company that is developing new immunotherapies that reprogram a patient’s innate immune system to allow the immune system to fight cancer and Alzheimer’s. We just interviewed the CEO Raymond J. Tesi, MD at Nasdaq. Let's check it out. 20190920 ...more
...more
【CEO INTERVIEW| INmune Bio CEO/CMO Raymond J. Tesi, MD】
6Likes
566Views
2019Sep 19
INmune Bio Inc. is a clinical stage biotechnology company that is developing new immunotherapies that reprogram a patient’s innate immune system to allow the immune system to fight cancer and Alzheimer’s. We just interviewed the CEO Raymond J. Tesi, MD at Nasdaq. Let's check it out. 20190920

Follow along using the transcript.

Wall Street Multimedia, Inc.

3K subscribers